Literature DB >> 29502620

Repeatability and reliability of ectasia display and topometric indices with the Scheimpflug system in normal and keratoconic eyes.

Pinar Kosekahya1, Mustafa Koc2, Mehtap Caglayan2, Hasan Kiziltoprak2, Cemile Ucgul Atilgan2, Pelin Yilmazbas2.   

Abstract

PURPOSE: To evaluate the repeatability and reliability of Belin-Ambrósio Enhanced Ectasia Display-III indices and topometric indices with a Scheimpflug system (Pentacam HR) in normal eyes and keratoconic eyes.
SETTING: Ulucanlar Eye Research and Training Hospital, Ankara, Turkey.
DESIGN: Prospective case series.
METHODS: The same operator performed 3 consecutive successive measurements with the Scheimpflug device in the eyes of patients with keratoconus (keratoconus group) and healthy volunteers (normal group). The keratoconus group was further classified into the following 3 subgroups according to the topographic keratoconus classification: early, moderate, and severe. One eye of each volunteer was assigned randomly to a repeatability test. The maximum keratometry (K), 6-parameter topometric indices, and 9 parameter ectasia display indices were recorded. The within-subject standard deviation, precision, repeatability indices, coefficient of variation, and intraclass correlation coefficient (ICC) values were calculated for repeatability and reliability assessments.
RESULTS: There were 100 patients in the keratoconus group and 100 healthy volunteers in the normal group. The maximum K, topometric indices except for index of height asymmetry, ectasia display indices except for deviation of normality of the front elevation, and deviation of normality of the back elevation were repeatable in normal eyes and keratoconic eyes. The repeatability indices of all parameters increased as the severity of keratoconus increased. The maximum K value and all indices showed good to excellent reliability in both groups (ICC values between 0.750 and 1.0 for all values).
CONCLUSION: The maximum K value, most topometric indices, and ectasia display indices were repeatable and reliable in normal eyes and keratoconic eyes.
Copyright © 2018 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29502620     DOI: 10.1016/j.jcrs.2017.10.042

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  Keratoconus after 40 years of age: a longitudinal comparative population-based study.

Authors:  Hassan Hashemi; Soheila Asgari; Shiva Mehravaran; Mohammad Hassan Emamian; Akbar Fotouhi
Journal:  Int Ophthalmol       Date:  2019-11-07       Impact factor: 2.031

2.  Comparison of obstructive sleep apnea syndrome and keratoconus patients on elevation maps.

Authors:  Umut Karaca; Dorukcan Akıncıoğlu; Onder Ayyildiz; Deniz Dogan; Gökhan Ozge; Gülşah Usta; Fatih Mehmet Mutlu
Journal:  Int Ophthalmol       Date:  2021-10-18       Impact factor: 2.031

3.  Comparison of corneal tomography using a novel swept-source optical coherence tomographer and rotating Scheimpflug system in normal and keratoconus eyes: repeatability and agreement analysis.

Authors:  Robert Herber; Janine Lenk; Lutz E Pillunat; Frederik Raiskup
Journal:  Eye Vis (Lond)       Date:  2022-05-23

4.  Diagnostic Sensitivity of Different Reference Bodies When Using Scheimpflug Tomography in a Myopic Population with Keratoconus.

Authors:  Daniel Garcerant; Ignacio Jiménez-Alfaro; Nicolás Alejandre
Journal:  J Ophthalmol       Date:  2019-07-18       Impact factor: 1.909

5.  Site of clear corneal incision in cataract surgery and its effects on surgically induced astigmatism.

Authors:  Junjie Piao; Choun-Ki Joo
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

6.  Comparison of variables measured with a Scheimpflug device for evaluation of progression and detection of keratoconus.

Authors:  Sophie Neuhann; Anna Schuh; Daniel Krause; Raffael Liegl; Valerie Schmelter; Thomas Kreutzer; Wolfgang J Mayer; Thomas Kohnen; Siegfried Priglinger; Mehdi Shajari
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.